Overview

Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

Status:
Completed
Trial end date:
2017-06-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of omadacycline as compared to linezolid in the treatment of adults with acute bacterial skin and skin structure infections.
Phase:
Phase 3
Details
Lead Sponsor:
Paratek Pharmaceuticals Inc
Treatments:
Linezolid